Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 23025519)

1.

Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.

Momper JD, Zhao Y, Shapiro R, Schonder KS, Gao Y, Randhawa PS, Venkataramanan R.

Transpl Infect Dis. 2013 Feb;15(1):34-41. doi: 10.1111/tid.12014. Epub 2012 Oct 2.

2.

Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.

Araya CE, Lew JF, Fennell RS 3rd, Neiberger RE, Dharnidharka VR.

Pediatr Transplant. 2006 Feb;10(1):32-7.

PMID:
16499584
3.

Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.

Kuypers DR, Vandooren AK, Lerut E, Evenepoel P, Claes K, Snoeck R, Naesens L, Vanrenterghem Y.

Am J Transplant. 2005 Aug;5(8):1997-2004.

4.

Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.

Vats A, Shapiro R, Singh Randhawa P, Scantlebury V, Tuzuner A, Saxena M, Moritz ML, Beattie TJ, Gonwa T, Green MD, Ellis D.

Transplantation. 2003 Jan 15;75(1):105-12.

PMID:
12544881
5.

Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients.

Cundy KC, Petty BG, Flaherty J, Fisher PE, Polis MA, Wachsman M, Lietman PS, Lalezari JP, Hitchcock MJ, Jaffe HS.

Antimicrob Agents Chemother. 1995 Jun;39(6):1247-52.

6.

Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.

Knight RJ, Gaber LW, Patel SJ, DeVos JM, Moore LW, Gaber AO.

Transplantation. 2013 Apr 15;95(7):949-54. doi: 10.1097/TP.0b013e31828423cd.

PMID:
23545506
7.

Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.

Cabello V, Margarit N, Díaz Pedrero M, Bernal G, Pereira P, Gentil MA.

Transplant Proc. 2008 Nov;40(9):2930-2. doi: 10.1016/j.transproceed.2008.09.002.

PMID:
19010151
8.

Treatment of refractory BK virus-associated nephropathy with cidofovir.

Kadambi PV, Josephson MA, Williams J, Corey L, Jerome KR, Meehan SM, Limaye AP.

Am J Transplant. 2003 Feb;3(2):186-91.

9.

Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant.

Savona MR, Newton D, Frame D, Levine JE, Mineishi S, Kaul DR.

Bone Marrow Transplant. 2007 Jun;39(12):783-7. Epub 2007 Apr 16.

PMID:
17438584
10.

Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis.

Wolf DL, Rodríguez CA, Mucci M, Ingrosso A, Duncan BA, Nickens DJ.

J Clin Pharmacol. 2003 Jan;43(1):43-51.

PMID:
12520627
11.

The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients.

Wu SW, Chang HR, Lian JD.

Nephrol Dial Transplant. 2009 Mar;24(3):1034-8. doi: 10.1093/ndt/gfn675. Epub 2008 Dec 4.

12.

Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience.

Kwon HJ, Kang JH, Lee JW, Chung NG, Kim HK, Cho B.

Transpl Infect Dis. 2013 Dec;15(6):569-74. doi: 10.1111/tid.12136. Epub 2013 Sep 13.

PMID:
24028353
13.

Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients.

Lim WH, Mathew TH, Cooper JE, Bowden S, Russ GR.

Nephrology (Carlton). 2003 Dec;8(6):318-23.

PMID:
15012704
14.

Anterior uveitis associated with treatment with intravenous cidofovir in kidney transplant patients with BK virus nephropathy.

Lopez V, Sola E, Gutierrez C, Burgos D, Cabello M, García I, Florez P, Lopez J, Gonzalez-Molina M.

Transplant Proc. 2006 Oct;38(8):2412-3.

PMID:
17097952
15.

Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature.

Lamoth F, Pascual M, Erard V, Venetz JP, Nseir G, Meylan P.

Antivir Ther. 2008;13(8):1001-9. Review.

PMID:
19195325
16.

Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach.

Ganguly N, Clough LA, Dubois LK, Mcguirk JP, Abhyankar S, Aljitawi OS, O'Neal N, Divine CL, Ganguly S.

Transpl Infect Dis. 2010 Oct;12(5):406-11. doi: 10.1111/j.1399-3062.2010.00513.x.

PMID:
20487411
17.
18.

Decline in native kidney function in liver transplant recipients is not associated with BK virus infection.

Salama M, Boudville N, Speers D, Jeffrey GP, Ferrari P.

Liver Transpl. 2008 Dec;14(12):1787-92. doi: 10.1002/lt.21627.

19.

Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients.

Hua DK, Howard K, Craig JC, Chapman JR, Wong G.

Transplantation. 2012 Jan 27;93(2):188-94. doi: 10.1097/TP.0b013e31823e7b0e.

PMID:
22186937
20.

Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy.

Araya CE, Lew JF, Fennell RS, Neiberger RE, Dharnidharka VR.

Pediatr Transplant. 2008 Nov;12(7):790-5. doi: 10.1111/j.1399-3046.2008.00937.x. Epub 2008 May 31.

PMID:
18537898
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk